GAPDH Antikörper (C-Term)

Produktnummer ABIN1440020

Produktdetails anti-GAPDH Antikörper

Target: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte, Kaninchen, Schwein, Huhn, Hund, Affe, Schaf, Rind (Kuh), Hamster, Cat, Pferd, Meerschweinchen, Ziege, Avian, Esel

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser GAPDH Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Spezifität: Detects a band of 37 kDa by Western blot in the following human (293A, HMEC-1, U-118, HaCat), rat (TR-iBRB), mouse (AtT-20, Hepa), canine (D17) and monkey (COS-7) whole cell lysates.

Produktmerkmale: Glyceraldehyde-3-phosphate dehydrogenase

Aufreinigung: epitope affinity purified

Immunogen: Purified recombinant peptide derived from within residues 240 aa to the C-terminus of human GAPDH produced in E. coli.

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 2 mg/mL

Buffer: Polyclonal antibody supplied as a 200 µL (2 mg/mL) aliquot in PBS, 20 % glycerol and 0.05 % sodium azide

Handhabung: The antibody solution should be gently mixed before use.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: For continuous use, store at 2-8 deg,C for one-two days. For extended storage, store in -20 deg,C freezer. Working dilution samples should be discarded if not used within 12 hours.

Referenzen für anti-GAPDH Antikörper (ABIN1440020)

Khalafalla, Kayani, Kassab, Ilves, Monsanto, Alvarez, Chavarria, Norman, Dembitsky, Sussman: "Empowering human cardiac progenitor cells by P2Y14 nucleotide receptor overexpression." in: The Journal of physiology, Vol. 595, Issue 23, pp. 7135-7148, (2018) (PubMed).

Gonçalves, Lin, Muthusamy, Fontes-Ribeiro, Ambrósio, Abcouwer, Fernandes, Antonetti: "Protective Effect of a GLP-1 Analog on Ischemia-Reperfusion Induced Blood-Retinal Barrier Breakdown and Inflammation." in: Investigative ophthalmology & visual science, Vol. 57, Issue 6, pp. 2584-92, (2017) (PubMed).

Hyenne, Apaydin, Rodriguez, Spiegelhalter, Hoff-Yoessle, Diem, Tak, Lefebvre, Schwab, Goetz, Labouesse: "RAL-1 controls multivesicular body biogenesis and exosome secretion." in: The Journal of cell biology, Vol. 211, Issue 1, pp. 27-37, (2016) (PubMed).

Helsby, Leader, Fenn, Gulsen, Bryant, Doughton, Sharpe, Whitley, Caunt, James, Pope, Kelly, Chalmers: "CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited." in: BMC cell biology, Vol. 15, pp. 6, (2014) (PubMed).

Details zu GAPDH

Target: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Andere Bezeichnung: GAPDH (GAPDH Produkte)

Hintergrund: GAPDH catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains.
Synonyms: glyceraldehyde 3-phosphate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, G3PD, GAPD, HGNC:4141, GAPDH antibody.
Ensembl identifier: ENSG00000111640